OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
Wenjia Chen, Helen K. Reddel, J Mark FitzGerald, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Wenjia Chen, Helen K. Reddel, J Mark FitzGerald, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
Ghislaine Scélo, Trung N. Tran, Tham Le, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2347-2361
Open Access | Times Cited: 8
Ghislaine Scélo, Trung N. Tran, Tham Le, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2347-2361
Open Access | Times Cited: 8
International Variation in Severe Exacerbation Rates in Patients With Severe Asthma
Tae Yoon Lee, David Price, Chandra Prakash Yadav, et al.
CHEST Journal (2024) Vol. 166, Iss. 1, pp. 28-38
Closed Access | Times Cited: 5
Tae Yoon Lee, David Price, Chandra Prakash Yadav, et al.
CHEST Journal (2024) Vol. 166, Iss. 1, pp. 28-38
Closed Access | Times Cited: 5
An evaluation of mepolizumab as an add-on maintenance treatment for severe eosinophilic asthma
Zheng Zhu, Xiaoying Chen, Yiting Luo, et al.
Expert Opinion on Biological Therapy (2025)
Closed Access
Zheng Zhu, Xiaoying Chen, Yiting Luo, et al.
Expert Opinion on Biological Therapy (2025)
Closed Access
The treatable traits approach to adults with obstructive airways disease in primary and secondary care
Mike Thomas, Richard Beasley
Respirology (2023) Vol. 28, Iss. 12, pp. 1101-1116
Open Access | Times Cited: 5
Mike Thomas, Richard Beasley
Respirology (2023) Vol. 28, Iss. 12, pp. 1101-1116
Open Access | Times Cited: 5
Advanced Approaches to Generating High-validity Real-world Evidence in Asthma
Karynsa Kilpatrick, Katherine N. Cahill, Uma Chandran, et al.
Epidemiology (2024) Vol. 36, Iss. 1, pp. 20-27
Open Access | Times Cited: 1
Karynsa Kilpatrick, Katherine N. Cahill, Uma Chandran, et al.
Epidemiology (2024) Vol. 36, Iss. 1, pp. 20-27
Open Access | Times Cited: 1
Anti-IL-5/anti-IL-5Rα treatment improves self-reported work productivity in patients with severe eosinophilic asthma – a prospective cohort trial
Lina Brinkmann, Jan Fuge, Tobias Welte, et al.
ERJ Open Research (2024) Vol. 10, Iss. 6, pp. 00374-2024
Open Access | Times Cited: 1
Lina Brinkmann, Jan Fuge, Tobias Welte, et al.
ERJ Open Research (2024) Vol. 10, Iss. 6, pp. 00374-2024
Open Access | Times Cited: 1
Biologics and Personalized Medicine in Severe Asthma: One Step at a Time
Richard Beasley, Lee Hatter
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 6, pp. 1771-1772
Open Access | Times Cited: 2
Richard Beasley, Lee Hatter
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 6, pp. 1771-1772
Open Access | Times Cited: 2
Promising treatment biomarkers in asthma
Barbara Bonnesen, Jens‐Ulrik Stæhr Jensen, Alexander G. Mathioudakis, et al.
Frontiers in Drug Safety and Regulation (2023) Vol. 3
Open Access | Times Cited: 2
Barbara Bonnesen, Jens‐Ulrik Stæhr Jensen, Alexander G. Mathioudakis, et al.
Frontiers in Drug Safety and Regulation (2023) Vol. 3
Open Access | Times Cited: 2
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
Wenjia Chen, Trung N. Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 2, pp. 536-539
Open Access
Wenjia Chen, Trung N. Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 2, pp. 536-539
Open Access
Can sputum eosinophils predict a poor response to mepolizumab?
Catherine Lemière, James G. Martin
Journal of Allergy and Clinical Immunology (2024)
Open Access
Catherine Lemière, James G. Martin
Journal of Allergy and Clinical Immunology (2024)
Open Access
Extending Personalized Evidence-Based Medicine in Severe Asthma
Richard Beasley, J Noble, Mark Weatherall
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2362-2363
Closed Access
Richard Beasley, J Noble, Mark Weatherall
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2362-2363
Closed Access
